Literature DB >> 33331320

[Analysis of diagnosis and treatment of 100 patients with Hürthle cell adenoma].

Q Kang1,2, J X Zhang3, Y Gao1, J Q Zhang1, X H Guo1.   

Abstract

OBJECTIVE: To summarize and analyze the clinical data and prognosis of the patients with Hürthle cell tumor (HCT) in order to raise the clinicians' awareness of the disease.
METHODS: The clinical data on patients with histopathologically proven HCT, without other thyroid carcinomas, were collected retrospectively in Peking University First Hospital from January 2001 to February 2017. All the patients underwent surgery due to thyroid nodules. The follow-up information was also collected.
RESULTS: A total of 100 patients were enrolled in the current study. All of them were diagnosed with Hürthle cell adenoma (HCA). There were 77 females and 23 males, with the male-to-female ratio of 1 : 3.3. The average age of these patients was (52±14) years at the time of operation. Fifty-one patients were found their thyroid nodules accidentally by ultrasonography during their health check-ups. 69.4% of the 49 symptomatic patients presented with painless cervical nodules. 83.0% HCA patients were combined with multinodular goiters (MNGs). 88.4% (76/86) patients were euthyroid and 53.8% (21/39) had increasing thyroglobulin levels. The mean longest diameter of HCAs was (3.2±1.5) cm (range: 0.9-7.3 cm) on ultrasonography. There were a series of sonographic features of HCA, such as larger, solidity, hypoecho, a smooth outline, intranodular vascularization, perinodular vascularization, absence of calcification in nodules and absence of enlarged cervical lymph nodes. Compared with the histological diagnosis, the diagnostic accuracy by frozen section (FS) during operation was 97.4%. Twenty-nine patients were followed up with an average period of (49.2±22.1) months and none of them had local recurrence or cervical lymph node metastasis. Six patients accepted thyroid hormone replacement treatment and one had thyrotoxicosis due to over-dose.
CONCLUSION: HCA is more common in women. It is often found accidentally by ultrasonography during their health check-ups or presented with painless cervical nodules. It is combined with MNG frequently. HCA exhibits numerous sonographic features but not unique. FS during operation is a reliable method to identify HCA with high diagnostic accuracy. Patients with thyroid hormone administration should be monitored for thyroid function after thyroid surgery.

Entities:  

Keywords:  Adenoma; Diagnosis; Hürthle cell tumor; Thyroid gland

Mesh:

Year:  2020        PMID: 33331320      PMCID: PMC7745266     

Source DB:  PubMed          Journal:  Beijing Da Xue Xue Bao Yi Xue Ban        ISSN: 1671-167X


  10 in total

1.  Hürthle cell neoplasm: correlation of gray-scale and power Doppler sonographic findings with gross pathology.

Authors:  Sang Kwon Lee; Byung Hak Rho; Seong-Ku Woo
Journal:  J Clin Ultrasound       Date:  2010-05       Impact factor: 0.910

2.  Hürthle cell neoplasms of the thyroid: are there factors predictive of malignancy?

Authors:  H Chen; T L Nicol; M A Zeiger; W C Dooley; P W Ladenson; D S Cooper; M Ringel; S Parkerson; M Allo; R Udelsman
Journal:  Ann Surg       Date:  1998-04       Impact factor: 12.969

3.  Fine needle aspiration cytology of the thyroid: a comparison of 5469 cytological and final histological diagnoses.

Authors:  G Sangalli; G Serio; C Zampatti; M Bellotti; G Lomuscio
Journal:  Cytopathology       Date:  2006-10       Impact factor: 2.073

4.  The RET/PTC oncogene is frequently activated in oncocytic thyroid tumors (Hurthle cell adenomas and carcinomas), but not in oncocytic hyperplastic lesions.

Authors:  Gennaro Chiappetta; Paolo Toti; Francesco Cetta; Ada Giuliano; Francesca Pentimalli; Ida Amendola; Stefano Lazzi; Mario Monaco; Luca Mazzuchelli; Piero Tosi; Massimo Santoro; Alfredo Fusco
Journal:  J Clin Endocrinol Metab       Date:  2002-01       Impact factor: 5.958

5.  Hürthle cell tumor of the thyroid: analysis of 188 cases.

Authors:  K Sugino; K Ito; T Mimura; K Kameyama; H Iwasaki; K Ito
Journal:  World J Surg       Date:  2001-09       Impact factor: 3.352

6.  Hürthle cell tumors.

Authors:  N Hillman; D Hardisson; L Herranz; M A Martinez Olmos; J A Hernandez Bayo; M Nistal; L F Pallardo
Journal:  Ann Med Interne (Paris)       Date:  1997

7.  Follicular Hurthle cell tumors of the thyroid gland.

Authors:  M L Carcangiu; S Bianchi; D Savino; I M Voynick; J Rosai
Journal:  Cancer       Date:  1991-11-01       Impact factor: 6.860

8.  Fine-needle aspiration of Hürthle cell lesions. A cytomorphologic approach to diagnosis.

Authors:  J L Gonzalez; H H Wang; B S Ducatman
Journal:  Am J Clin Pathol       Date:  1993-09       Impact factor: 2.493

9.  Tumor size predicts malignant potential in Hürthle cell neoplasms of the thyroid.

Authors:  Rebecca S Sippel; Dina M Elaraj; Elham Khanafshar; Rasa Zarnegar; Electron Kebebew; Quan-Yang Duh; Orlo H Clark
Journal:  World J Surg       Date:  2008-05       Impact factor: 3.352

10.  Oncocytic cell tumors of the thyroid: factors predicting malignancy and influencing prognosis, treatment decisions, and outcomes.

Authors:  Adolfo Pisanu; Barbara Di Chiara; Isabella Reccia; Alessandro Uccheddu
Journal:  World J Surg       Date:  2010-04       Impact factor: 3.352

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.